Schroder Prime UK Equity Fund S Income GBPRegister to Unlock Ratings |
Performance History | 31/10/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | -6.2 | 12.9 | 1.6 | 6.4 | 8.1 | |
+/-Cat | 2.9 | -5.0 | 3.7 | -1.8 | 0.8 | |
+/-B’mrk | - | - | - | -1.2 | -0.1 | |
Category: UK Large-Cap Equity | ||||||
Category Benchmark: Morningstar UK All Cap TME ... |
Key Stats | ||
NAV 22/11/2024 | GBX 57.93 | |
Day Change | 1.31% | |
Morningstar Category™ | UK Large-Cap Equity | |
IA (formerly IMA) Sector | UK All Companies | |
ISIN | GB00BDZTQQ07 | |
Fund Size (Mil) 21/11/2024 | GBP 627.65 | |
Share Class Size (Mil) 21/11/2024 | GBP 0.00 | |
Max Initial Charge | - | |
Ongoing Charge 06/02/2024 | 0.32% |
Investment Objective: Schroder Prime UK Equity Fund S Income GBP |
The Fund aims to provide capital growth in excess of the FTSE All Share (Gross Total Return) index (after fees have been deducted) over a three to five year period by investing in equity and equity related securities of UK companies. The Fund is actively managed and invests at least 80% of its assets in equity and equity related securities of UK companies. These are companies that are incorporated, headquartered or have their principal business activities in the UK. |
Returns | ||||||||||||||||
|
Management | ||
Manager Name Start Date | ||
Sue Noffke 31/07/2006 | ||
Matthew Bennison 30/09/2017 | ||
Click here to see others | ||
Inception Date 07/04/2017 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
FTSE AllSh TR GBP | Morningstar UK All Cap TME NR GBP |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Schroder Prime UK Equity Fund S Income GBP | 31/07/2024 |
|
|
Top 5 Holdings | Sector | % |
AstraZeneca PLC | Healthcare | 6.82 |
Shell PLC | Energy | 6.39 |
Schroder Instl UK Smaller Cos I Inc | 6.11 | |
GSK PLC | Healthcare | 4.29 |
QinetiQ Group PLC | Industrials | 3.71 |
Increase Decrease New since last portfolio | ||
Schroder Prime UK Equity Fund S Income GBP |